比利时的CDMO Ardena扩大了荷兰用于药物开发的生物分析服务。 Belgian CDMO Ardena expands bioanalytical services in the Netherlands for drug development.

比利时的CDMO公司Ardena正在扩大其在荷兰的生物分析服务,以满足制药和生物技术工业不断增长的需求。 Ardena, a Belgian CDMO, is expanding its bioanalytical services in the Netherlands to meet the rising demand in the pharmaceutical and biotechnology industries. 这包括Oss的Pivot公园的新实验室,该实验室于2025年Q1投入运行,Assen设施的能力得到加强。 This includes a new lab at its Pivot Park in Oss, operational by Q1 2025, and enhanced capabilities at its Assen facility. 在Ardena最近从加泰隆尼亚购买美国制造设施之后,这些扩大将支持药物发展各阶段的客户。 The expansions will support clients at all stages of drug development, following Ardena's recent acquisition of a U.S. manufacturing facility from Catalent.